Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer

Explore clinical trials studying Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer trial results

Completed

AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT02296125

Conditions: Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
Locations: Research Site Anaheim, California, United States

Research Site Santa Rosa, California, United States

Research Site West Hills, California, United States

Research Site Tampa, Florida, United States

View all 170 locations

View Trial Details